<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Novo Nordisk: Det ligner det &quot;naturlige&quot; comeback]]></title><description><![CDATA[<p dir="auto">Kommentar fra Per hansen, investeringsøkonom, Nordnet</p>
<p dir="auto">Novo Nordisk faldt mandag med 2,92 % i Danmark. Reelt var faldet større. Måske er der udsigt til et kursmæssigt comeback tirsdag</p>
<p dir="auto">Novo Nordisk sluttede fredag i 388 i Danmark<br />
I USA sluttede Novo Nordisk i fredags i 401. I fredagens eftermarked sluttede aktien i 404<br />
Mandag faldt Novo Nordisk "officielt" med 2,92 % i Danmark. De seneste kvartaler har det været i USA, hvor aktien er blevet prissat. Derfor kan man godt hævde, at aktien rent faktisk faldt med mere end 6 % (404 vs 378)<br />
Fra morgenstunden indikeres Novo Nordisk i 60,67 i USA. Det svarer til 388 omregnet med USD/DKK 6,40<br />
I givet fald vil det svare til en stigning på 2,6 %, når handlen starter i Danmark; hvis det er USA indikationer der driver prisen og hvis formarkedspriserne ikke ændrer sig før handlen åbner</p>
<p dir="auto">Figur: USA formarkedspriser, Novo Noridisk, 6,30 tirsdag morgen<br />
Kilde: Yahoo Finance</p>
<p dir="auto"><img src="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/130788_image_70_.png" alt="130788_image_70_.png" class=" img-fluid img-markdown" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/447949/novo-nordisk-det-ligner-det-naturlige-comeback</link><generator>RSS for Node</generator><lastBuildDate>Thu, 11 Jun 2026 04:20:50 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/447949.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 20 Jan 2026 04:54:27 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Novo Nordisk: Det ligner det &quot;naturlige&quot; comeback on Thu, 22 Jan 2026 19:38:21 GMT]]></title><description><![CDATA[<p dir="auto">Many patients may keep off lost pounds after stopping a GLP-1, US data suggests - <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/many-patients-may-keep-off-lost-pounds-after-stopping-glp-1-us-data-suggests-2026-01-22/" rel="nofollow ugc">https://www.reuters.com/business/healthcare-pharmaceuticals/many-patients-may-keep-off-lost-pounds-after-stopping-glp-1-us-data-suggests-2026-01-22/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9496518</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9496518</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Thu, 22 Jan 2026 19:38:21 GMT</pubDate></item><item><title><![CDATA[Reply to Novo Nordisk: Det ligner det &quot;naturlige&quot; comeback on Thu, 22 Jan 2026 08:11:54 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk expands diabetes cell therapy partnership with Aspect Biosystems - <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-expands-diabetes-cell-therapy-partnership-with-aspect-biosystems-2026-01-20/" rel="nofollow ugc">https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-expands-diabetes-cell-therapy-partnership-with-aspect-biosystems-2026-01-20/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9496519</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9496519</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Thu, 22 Jan 2026 08:11:54 GMT</pubDate></item></channel></rss>